Just hours after the Trump administration dropped its nominee to lead the Food and Drug Administration, a key Senate committee pulled the plug on a vote for the White House nominee to lead the National Science Foundation (NSF) as well.

On Tuesday, the White House announced it would not move forward with Heidi Overton’s candidacy for Commissioner of the Food and Drug Administration. And on Wednesday during opening remarks for a hearing of the Senate Health, Education, Labor and Pensions Committee, Senator Bill Cassidy said Jim O’Neill, who previously served as acting director for the Centers of Disease Control and Prevention (CDC), would not be considered to lead the NSF.

O’Neill “did not do enough to stand up for science and against irresponsible decisions and statements from [Health and Human Services Secretary Robert Kennedy, Jr.],” Cassidy said. “His role in the firing of Dr. Susan Monarez raised further concerns about the independent judgment he would bring to this effort.”


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Monarez was fired as CDC director in 2025, a move she blamed on her refusal to approve vaccine recommendations that lacked evidence or fire agency employees without cause. Kennedy, whose department oversees the CDC, is a longtime vaccine skeptic. O’Neill is widely considered a key Kennedy ally and proponent of the ‘Make America Healthy Again’ movement. Many science advocates and organizations such as a the Union of Concerned Scientists had campaigned against his nomination, citing his time as acting CDC director and his background in biotechnology investing as reasons he should not be considered for the job.

The White House and the NSF did not immediately respond to a request for comment.

In a post on X in the wake of Overton’s removal, Cassidy said she had a “viable confirmation path,” but the White House did not believe she had the votes.

“This was odd as I was having productive conversations with members,” Cassidy wrote. “I believe she would have had the votes to pass out of committee and pass the full Senate. My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk.”

Cassidy alleged that the only issue that stood in the way of Overton’s confirmation was anti-abortion senators seeking assurances from the White House that the FDA would back their agenda.

“The Administration withdrew Dr. Overton rather than make such commitments,” he wrote. “Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats.”

Although Overton had praised Trump during her confirmation hearing in September, she also distanced herself from some of his more outlandish positions, telling the committee that Tylenol use during pregnancy does not cause autism and the mumps, measles and rubella is safe and effective. She also said the abortion drug mifepristone met FDA safety and efficacy standards. The drug has been at the center of legal efforts to reduce abortion access, with antiabortion proponents falsely claiming the drug is unsafe.

This is a breaking news story and may be updated.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Source: Scientific American · Adam Kovac

At a glance

Topic
Politics
Country
🇺🇸 US
Publisher language
EN
Added to Allnira